Data / Form D filings / Longeveron Inc.
Longeveron Inc.: Form D filings
Longeveron Inc., a biotechnology company in Miami, FL, filed 11 Form D notices with the SEC between 2017 and 2026. The latest, on March 25, 2026, reports $15.9 million sold of a $33.5 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1951 NW 7TH AVENUE SUITE 520, Miami, FL, 33136
- Phone
- (305) 909-0840
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1721484
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 25, 2026 | New notice | $33,515,000 | $15,890,000 | $17,625,000 | 7 | Mar 11, 2026 | sec.gov |
| Jul 23, 2024 | New notice | $9,508,010 | $0 | $9,508,010 | 3 | Jul 19, 2024 | sec.gov |
| Jun 25, 2024 | New notice | $9,444,516 | $0 | $9,444,516 | 3 | Jun 18, 2024 | sec.gov |
| Apr 25, 2024 | New notice | $12,424,674 | $0 | $12,424,674 | 3 | Apr 18, 2024 | sec.gov |
| Jan 8, 2024 | New notice | $2,571,942 | $0 | $2,571,942 | 1 | Dec 22, 2023 | sec.gov |
| Oct 24, 2023 | New notice | $8,350,001 | $0 | $8,350,001 | 1 | Oct 13, 2023 | sec.gov |
| Dec 13, 2021 | New notice | $20,462,545 | $20,462,545 | 20 | Dec 3, 2021 | sec.gov | |
| Feb 6, 2020 | New notice | $25,000,000 | $100,000 | $24,900,000 | 1 | Jan 22, 2020 | sec.gov |
| Feb 6, 2020 | Amendment | $25,000,000 | $954,970 | $24,045,030 | 5 | Oct 20, 2017 | sec.gov |
| Apr 5, 2018 | Amendment | $25,000,000 | $524,970 | $24,475,030 | 2 | Oct 20, 2017 | sec.gov |
| Nov 6, 2017 | New notice | $9,000,000 | $299,970 | $8,700,030 | 1 | Oct 20, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Stephen H. Willard | Executive Officer | |
| Joshua M. Hare | Executive Officer, Director | |
| Lisa A. Locklear | Executive Officer | |
| Nataliya Agafonova | Executive Officer | |
| Paul Lehr | Executive Officer | |
| Devin Blass | Executive Officer | |
| Rock Soffer | Director | |
| Ursula Ungaro | Director | |
| Roger Joseph Hajjar | Director | |
| George Paletta, Jr. | Director |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of Mar 23, 2026 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Longeveron Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.